EARNEST Partners
ASTH icon

EARNEST Partners’s Astrana Health ASTH Stock Holding History

EARNEST Partners’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Buy
258,991
+38,996
+18% +$1.4M 0.04% 184
2026
Q1 		$5.39M Buy
219,995
+24,502
+13% +$580K 0.02% 197
2025
Q4 		$4.85M Buy
+195,493
New +$5.19M 0.02% 209

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EARNEST Partners's ASTH Position: Q2 2026 in Review

EARNEST Partners increased its Astrana Health (ASTH) stake by 18% in Q2 2026, buying an estimated $1.4M and bringing the position to 258,991 shares worth $12M. The position accounts for 0.04% of the portfolio, ranked #184.

EARNEST Partners first reported a position in ASTH in Q4 2025 and has held it in 3 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • EARNEST Partners held 258,991 shares of Astrana Health worth $12M as of Q2 2026.
  • EARNEST Partners bought 38,996 Astrana Health shares in Q2 2026, an estimated $1.4M.
  • Astrana Health made up 0.04% of EARNEST Partners's portfolio in Q2 2026, its #184 holding.
  • EARNEST Partners first reported a position in Astrana Health in Q4 2025 and has held it in 3 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on EARNEST Partners's 13F filing for Q2 2026, filed 13 Aug 2026.